Therapeutic modulation of the intestinal creatine kinase system in inflammatory bowel disease (IBD)
Specific Aim 1: Determine whether creatine supplementation induces improvement in the endoscopic assessment of mucosal inflammation in ulcerative colitis (UC). Specific Aim 2: Evaluate the feasibility of the current study protocol. Specific Aim 3: Assess the impact of creatine supplementation on intestinal epithelial barrier function and the intestinal microbiome.
University of Colorado Hospital
Mark Gerich, MD
Protocol Number: 13-3054
More information available at ClinicalTrials.gov: NCT02463305
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers